STKLMEDIUM SIGNALFINANCIAL10-K

STKL's revenue grew 13% with improved gross margins, but cash position deteriorated dramatically while accounts receivable expanded substantially.

The company appears to be growing but potentially struggling with cash conversion as receivables increased much faster than revenue growth, suggesting collection challenges or extended payment terms. The severe cash decline to just $169K creates meaningful liquidity risk despite overall revenue expansion.

Comparing 2026-03-04 vs 2025-02-26View on EDGAR →
FINANCIAL ANALYSIS

STKL delivered solid top-line growth with revenue increasing 13% to $817.7M and gross profit expanding 20.4% to $115.9M, indicating improved operational efficiency supported by reduced SG&A expenses. However, the balance sheet reveals concerning trends with cash plummeting 89% to just $169K while accounts receivable surged 63% to $75.6M, suggesting potential working capital management issues. The substantial gap between revenue growth and receivables expansion raises questions about collection effectiveness and cash flow generation despite the positive revenue trajectory.

FINANCIAL STATEMENT CHANGES
Cash & Equivalents
Balance Sheet
-89.1%
$1.6M→$169K

Cash declined 89.1% — significant cash burn or deployment; verify adequacy of remaining liquidity runway.

Accounts Receivable
Balance Sheet
+63.2%
$46.3M→$75.6M

Receivables surged 63.2% — revenue recognized but not yet collected; watch for collection issues or channel stuffing.

Current Assets
Balance Sheet
+37.8%
$159.5M→$219.8M

Current assets grew 37.8% — improving short-term liquidity or inventory/receivables build.

Gross Profit
P&L
+20.4%
$96.3M→$115.9M

Gross profit expanding — improving pricing power or product mix shift toward higher-margin offerings.

Inventory
Balance Sheet
+15.3%
$92.8M→$107.0M

Inventory built 15.3% — monitor whether demand supports this build or if write-downs may follow.

Stockholders Equity
Balance Sheet
+14.9%
$148.6M→$170.8M

Equity base grew 14.9% — retained earnings accumulation or equity issuance strengthening the balance sheet.

Revenue
P&L
+13%
$723.7M→$817.7M

Revenue growing 13% — solid top-line momentum, watch margins for quality of growth.

SG&A Expense
P&L
-10.6%
$79.4M→$71.0M

SG&A reduced 10.6% — improved cost efficiency or headcount reduction improving operating margins.

LANGUAGE CHANGES
NEW — 2026-03-04
PRIOR — 2025-02-26
ADDED
In this report, all currency amounts presented are expressed in United States ("U.S.") dollars ("$"), unless otherwise stated.
2 January 3, 2026 Form 10-K All forward-looking statements made herein are qualified by these cautionary statements, and our actual results or the developments we anticipate may not be realized.
We deliver customized supply chain solutions and innovation for top brands, retailers, and foodservice providers across a broad portfolio of beverages, broths, and better-for-you snacks.
Our plant-based beverage offerings include oat, almond, soy, coconut and rice milks, which have a favorable climate profile relative to traditional dairy milks in terms of lower carbon emissions and water usage.
Our portfolio includes non-genetically modified ("non-GMO"), organic, and gluten-free products.
We distribute our products through retail, club, foodservice and e-commerce channels.
Arrangement Agreement On February 6, 2026, we entered into an Arrangement Agreement (the "Arrangement Agreement") with Pegasus BidCo B.V.
Pursuant to the Arrangement, at the closing, each of our issued and outstanding common shares (other than shares held by dissenting shareholders, if any) will be transferred to Purchaser for consideration of $6.50 per share in cash, less applicable withholdings.
The Arrangement is expected to close in the second quarter of 2026, subject to satisfaction or waiver of the closing conditions, including receipt of court and regulatory approvals, and subject to the approval of our shareholders.
Upon completion of the transaction, we will become a wholly-owned subsidiary of Refresco, and our common shares will be delisted from The Nasdaq Stock Market and the Toronto Stock Exchange.
REMOVED
In this report, all currency amounts presented are expressed in thousands of United States ("U.S.") dollars ("$"), except per share amounts, unless otherwise stated.
2 December 28, 2024 Form 10-K All forward-looking statements made herein are qualified by these cautionary statements, and our actual results or the developments we anticipate may not be realized.
We operate as an innovation partner, solutions provider, and value-added manufacturer for leading brands, and produce our own propriety brands, including SOWN , Dream and West Life .
The core of our product portfolio is a range of plant-based beverages, including oat, almond, soy, coconut and rice milks and creamers, which have a favorable climate profile relative to traditional dairy milks in terms of lower carbon emissions and water usage.
Our plant-based offerings include non-genetically modified ("non-GMO"), organic, and gluten-free products.
Additionally, our consumer products portfolio includes fruit snacks, nutritional beverages, broths, and teas.
In 2024, our ten largest customers accounted for approximately 80% of our revenues.
The costs of raw materials used in our products also fluctuate due to energy costs, fuel prices, labor availability, freight and storage demand, and changes in tariff rates.
We rely on our packaging suppliers to ensure delivery of often unique, portable, and convenient consumer packaging formats.
4 December 28, 2024 Form 10-K Seasonality Overall, the demand for most of our products does not typically fluctuate significantly in any particular season; however, broth sales are generally higher in the first and fourth quarters of each year.
MORE FINANCIAL SIGNALS
CRMHIGHSalesforce significantly increased debt by 71% to $14.4B while simultaneously ac...
2026-03-02
UNHHIGHUNH's operating income plummeted 41% despite 12% revenue growth, indicating seve...
2026-03-02
PFEHIGHPfizer achieved a dramatic 87.3% reduction in total debt from $31.4B to $4.0B, r...
2026-02-26
GILDHIGHGILD dramatically increased R&D spending by 81.5% to $9.1B while introducing new...
2026-02-24
ANALYZE ANY FILING FREE

See what changed in your portfolio's filings

500+ US-listed companies analyzed. Language delta, financial analysis, instant signal scoring.

Try Tracenotes free →